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ABSTRACT
RNA interference is a powerful mechanism for
sequence-specific inhibition of gene expression. It
is widely known that small interfering RNAs
(siRNAs) targeting the same region of a
target-messenger RNA can have widely different
efficacies. In efforts to better understand the siRNA
features that influence knockdown efficiency, we
analyzed siRNA interactions with a high-molecular
weight complex in whole cell extracts prepared
from two different cell lines. Using biochemical
tools to study the nature of the complex, our results
demonstrate that the primary siRNA-binding protein
in the whole cell extracts is Dicer. We find that Dicer
is capable of discriminating highly functional versus
poorly functional siRNAs by recognizing the
presenceof2-nt 30 overhangs andthethermodynam-
ic properties of 2–4bp on both ends of effective
siRNAs. Our results suggest a role for Dicer in
pre-selection of effective siRNAs for handoff to
Ago2. This initial selection is reflective of the overall
silencing potential of an siRNA.
INTRODUCTION
RNA interference (RNAi) is an evolutionarily conserved
process mediated by a multi-component ribonucleoprotein
complex called the RNA induced silencing complex
(RISC) (1–2). RNAi can be described as having at least
two well-deﬁned steps: the initiation step, where the ribo-
nuclease (RNase) III enzyme Dicer processes dsRNAs
into 21–22-nt-long duplexes (3), and the effector step, in
which Argonaute 2 (Ago 2), a core endonuclease of the
RISC, executes RNAi (4–6). Two classes of small regula-
tory RNAs—small interfering RNAs (siRNAs) and
microRNAs (miRNAs)—are shown to associate with
RISC as RNAi trigger molecules. SiRNAs, 21–23nt
fully complementary double-stranded RNAs (dsRNAs)
with 2-nt 30 overhangs, guide sequence-speciﬁc degrad-
ation of complementary messenger RNAs once
incorporated into RISC (7–10). In contrast, miRNAs
form imperfect duplexes with the target mRNAs, most
often in the 30-UTR, and the miRNA-containing RISC
blocks translation or leads to destabilization of the
targeted message (11–18).
The RNAse III family member Dicer, along with
co-factor RNA-binding proteins, processes long dsRNAs
and pre-miRNAs into the functional 21–23-nt siRNA or
miRNA duplexes. The functional roles of Dicer have been
most well studied in Drosophila where two distinct
enzymes are involved in parallel pathways for small regu-
latory RNA biogenesis. Dicer-2 (Dcr-2) processes
long-double-stranded precursors and generates siRNAs
(19,20) while Dicer-1 (Dcr-1) processes pre-miRNAs into
mature miRNAs (20). Importantly, these two enzymes
utilize different co-factors for their respective functions.
Dcr-1 is associated with the dsRNA-binding protein
Loquacious (Loqs) (21,22) whereas Dcr-2 is associated
with the dsRNA-binding protein R2D2 (19,23). In
contrast, mammals possess only a single species of Dicer
in association with the dsRNA-binding protein TRBP,
which participates in both si- and miRNA biogenesis
(24,25). Given this fundamental difference between
human and ﬂy RNAi pathways, we sought to characterize
the mechanism by which highly functional siRNAs are
selected in humans.
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(TRBP) has been characterized as one of the factors that
assemble Dicer-generated small RNAs into RISC by inter-
acting directly with Dicer and Ago2 (26–29). TRBP has
been shown to have versatile roles in small regulatory
RNA biogenesis. TRBP has high-sequence similarity to
Drosophila Loqs and mammalian PACT (30), and is
required for both si- and miRNA silencing (27,29). The
Dicer-TRBP interaction is RNA independent (29). TRBP
is required for the recruitment of Ago2 to the siRNA–
Dicer complex (27) and is proposed to participate in
coupling of the RNAi initiation and effector steps.
Other studies have shown that MOV10 (31,32) and
RNA Helicase A (33) are additional factors that associate
with human RISC, forming an active complex. However,
little is known about their modes of action in RNAi.
The selection of the guide strand which serves as a
sequence-speciﬁc RNAi trigger largely determines the
efﬁcacy of RNAi (3). Effective siRNAs most often have
a thermodynamically unstable 50 guide strand end (34),
and often have asymmetric loading of the guide versus
passenger strands (35). In Drosophila, the orientation of
the guide strand of the siRNA is determined by the Dcr-2/
R2D2 heterodimer siRNA binding, with Dcr-2 binding at
the 50-end of the guide strand and R2D2 binding the
50-end of the passenger strand (36). R2D2 is also sensitive
to the 50-end stability and the presence of 50 phosphates on
the siRNA (36).
In comparison to observations with the siRNAs, which
often show a wide range of potency (37–39), Dicer pro-
cessing of its substrates during the initiation step of RNAi
was shown to result in better programming of RISC
(9,19,28). Furthermore the polarity of Dicer processing
preferentially deﬁnes which strand serves as the guide
(40). Conversely, it is known that Dicer processing is dis-
pensable for RISC assembly and siRNA-mediated
cleavage of target-RNA transcripts when siRNAs were
exogenously introduced into cells lacking functional
Dicer (41–43). Interestingly, in Drosphila, an organism
which expresses both siRNAs and miRNAs as regulatory
small RNAs, the Dcr-2/R2D2 heterodimer was shown to
act as a gatekeeper promoting the incorporation of
siRNAs for assembly with Ago2 while disfavoring
miRNAs as loading substrates for Ago2 (44). The
sorting process depends upon the structure of the small
RNA duplex and not upon Dcr-2 cleavage.
Aside from the appropriate selection of the guide strand
for incorporation into RISC, there is the concern of
off-targeting in which either the sense or antisense
strand binds to non-targeted sequences triggering inhib-
ition of expression of these transcripts (45–48). Therefore
in order to enhance the efﬁcacy of RNAi, it is essential to
better understand the mechanism of siRNA selection and
strand incorporation in the RNA-silencing pathway.
Here we show that siRNAs associate with a
high-molecular weight complex in HEK293 and HCT116
whole cell extracts. The degree of this association varies
from siRNA to siRNA, in some cases dramatically
between two siRNAs differing by only a single base
pair. We observe that Dicer is the core siRNA-
duplex-binding component of the whole cell extract
complex. Dicer preferentially recognizes the 2-nt 30 over-
hangs and thermodynamically unstable ends. Since Dicer
can bind to a siRNA duplex in either orientation, either
strand of the duplex can be selected as the guide strand
based on the thermodynamic end properties of the duplex.
Thus, when siRNAs are delivered exogenously to cells,
human Dicer (most likely in the form of a complex with
TRBP and Ago2) serves as the primary sensor for the
selection of highly functional siRNAs leading to handoff
to Ago2. This selective process is based upon the presence
of ribose 2-nt 30 overhangs and the thermodynamic end
properties of the siRNAs. When siRNAs cannot interact
with Dicer, such as in Dicer null cells, they can bypass the
Dicer-binding step and directly enter RISC. Nevertheless
when Dicer is present, it serves as a primary sensor for
siRNA selection when the siRNAs contain an appropriate
structure.
MATERIALS AND METHODS
Synthetic siRNAs
All siRNAs used in this study were synthesized by IDT
(Coralville, Iowa). The siRNAs were puriﬁed using
high-performance liquid chromatography. The sequences
are listed in Figures 1 and 3.
Cell extracts
HEK293 cells were grown to conﬂuency in 10-cm dishes,
harvested and washed with 1x PBS. The cell pellet was
re-suspended in 0.5ml of buffer D (20mM HEPES, pH.
7.9, 0.2mM EDTA, 0.5mM DTT, 50mM KCl, 10%
Glycerol, 0.2mM PMSF) and sonicated three times for
20 s on ice with a Soniﬁer 450 (Branson, Danbury, CT)
at a setting of 60. The supernatants were collected after
15min of microcentrifugation for direct use in subsequent
experiments.
Dual luciferase reporter assays
To generate reporter plasmids psi-hnRNPH-S (sense
reporter) and psi-hnRNPH-AS (antisense reporter), a
343-bp PCR fragment of hnRNPH cDNA (Acc.:
NM_005520) was cloned in the 30-UTR of the humanized
Renilla luciferase gene in the psiCHECK
TM-2 vector
(Promega) in either the sense or antisense orientation
(40). HCT116 cells at 60–80% conﬂuence in 24-well
plates were transfected in duplicate or triplicate with
100ng of reporter DNA, 25–200 pM siRNA and 0.5ml
Lipofectamine2000 per well, in a total transfection
volume of 500ml. Cells transfected with an irrelevant
siRNA were used as mock controls, and an average was
calculated from the replicates to set Renilla/Fireﬂy
luciferase expression to 100%.
For EGFP repression, psi-EGFPS1-S (sense reporter)
or psi-EGFPS1-AS was generated by cloning a 245-bp
PCR fragment of EGFP in either the sense or antisense
orientation in the 30-UTR of the psiCHECK
TM-2 vector
(Promega) (40). Forty nanograms of reporter DNA, 20 or
200 pM siRNA and 0.5ml Lipofectaimine2000 per well
were used to transfect HEK293 cells in duplicate at
Nucleic Acids Research,2011, Vol.39, No. 4 151160–80% conﬂuency in 48-well plates, in a total transfec-
tion volume of 200ml. HEK293 cell lysates were collected
24-h post-transfection and subjected to Dual Luciferase
assays (Promega). Transfection was done in duplicate
and repeated at least three times. Renilla luciferase expres-
sion was normalized to internal control Fireﬂy luciferase
expression. Cells transfected with an irrelevant siRNA
were used as mock controls, and an average was
calculated from the replicates to set Renilla/Fireﬂy
luciferase expression to 100%.
For siDicer, siAgo2 or siTRBP treatment, HEK293
cells were seeded on 10-cm dishes and transfected
with 40-nM siRNA-targeting Dicer, Ago2 or TRBP. The
sequences of the siRNAs used in this study are as
follows: Dicer, 50-UUUGUUGCGAGGCUGAUU
CdTdT-30; Ago2, 50-GCACGGAAGUCCAUCUGA
AdTdT-30; TRBP, 50-UCUACGAAAUUCAGUAGG
AdTdT-30. Forty-eight hours later, the siRNA treated
cells were seeded on either 48-well plates or 6-well plates
for Dual Luciferase assays or RT-qPCR, respectively. In
the second-round transfection, the same procedure
described above was used for Dual Luciferase assays.
Either with or without 20-nM siDicer, siAgo2 or
siTRBP in the second round of transfection produced
the same results.
IC50 measurements
To generate 50% inhibitory concentration (IC50) curves,
HEK293 or HCT116 cells at 60–80% conﬂuency in
48-well plates were transfected in duplicate with 40ng of
reporter DNA (either psiEGFPS1-S or –AS with HEK293
cells and psi-H1-S or –AS with HCT116 cells), siRNAs
ranging from 0.2pM to 15nM in serial dilutions (a
minimal of 10 points measurements) and 0.5ml
Lipofectaimine2000 per well in a total transfection
volume of 200ml. Cell lysates were collected 24-h
post-transfection and subjected to the Dual-Luciferase
Reporter Assay System (Promega). For each siRNA,
transfection was carried out in duplicate and repeated at
least three times. Normalization of Renilla luciferase ex-
pression to internal control Fireﬂy luciferase expression
was as described above. IC50 curves were generated with
GraphPad Prism version 5.01 using the dose response
curve equation: Y=Bottom+(Top – Bottom)/
(1+10[(LogIC50 – X) HillSlope)] with variable slope.
The 95% conﬁdence intervals of IC50 values for siRNAs
in this study are listed in Figures 3 and 4.
Recombinant proteins
N-terminally His6x-tagged TRBP2 was expressed from the
pET11a (+) vector (Novagen) in the Escherichia coli
BL21DE3 strain. Following 4-h induction with 0.5mM
IPTG, puriﬁcation of His6x-TRBP2 was performed with
Nickel-Nitrilotriacetic acid (Ni
2+-NTA) (the QIA expres-
sion system, Qiagen) under denaturing conditions.
Efﬁciency of elution steps was determined with 12%
SDS–PAGE/coomassie blue staining. The protein was
further puriﬁed by dialyzing with a 3500 MWCO
dialysis cassette (#66110, PIERCE, Rockford, IL),
concentrated with an Amicon Ultra centrifugal ﬁlter
30KNMWL and stored in buffer D containing 10mM
TCEP. Purity of His-TRBP was also determined by
Coomassie blue staining and western-blot analyses (49)
with an a-His tag antibody (ab18184, Abcam Inc.,
Cambidge, MA). Recombinant human Dicer was
purchased from Ambion, and its concentration was
determined with A205 measurements. Titration-binding
assays were performed to evaluate optimal concentrations
of the recombinant proteins (data not presented), ranging
from 0.1mgt o5mg for Dicer and 4ng to 300ng for TRBP,
2mg of rDicer enzyme and 80ng of rTRBP were used in
subsequent gel shift assays (Figure 5).
Immunodepletion assays
Immunodepletion analyses were carried out as previously
described (49). To immunodeplete Dicer, TRBP or Ago 2
from HEK293 whole cell extracts, 2mg of pre-cleared
extract were incubated with each primary antibody—
a-Dicer (15mg of sc-30226, Santa Cruz Biotechnology,
Inc., Santa Cruz, CA), a-TRBP [25ml of TRBP-JBX,
(50)], a-Ago2 (15mg of ab57113, Abcam Inc.,
Cambridge, MA). In the case of Dicer/TRBP or Ago2/
TRBP double immunodepletion, TRBP precipitation
was performed following Dicer or Ago2 precipitations.
Pre-immune serum (2.5ml of sc-2007 or sc-2025, Santa
Cruz Biotechnology, Inc.) was used as a control.
Following 2-h incubation, protein A/G plus agarose
beads (Santa Cruz Biotechnology, Inc.) were added and
incubated overnight at 4 C with gentle agitation. The fol-
lowing day, supernatants were collected for additional in-
cubation with the beads for 6h. After removing the beads
by a brief microcentrifugation, buffer D was added to
bring the cell extracts to a ﬁnal concentration of 4mg/
ml. Of total protein extracts, 15mg were used in the Gel
Shift assays. Of the cell extracts, 150mg were also used in
western-blot analyses to evaluate the efﬁciency of the
immunodepletions. Equal amounts of total protein were
electrophoresed in SDS–PAGE gels (16cm 16cm), and
each protein was detected sequentiqlly. After conﬁrming
the reproducibility of the procedure, the membrane was
cut in three pieces to detect Dicer ( 215kDa), Ago2
( 100kDa), TRBP ( 40kDa) and b-actin ( 37kDa),
and the whole membrane was scanned at once for consist-
ency using two different wave lengths. Antibodies a-Dicer
(ab14601, Abcam Inc.), a-Ago2 (ab57113, Abcam Inc.),
a-TRBP (ab42018, Abcam Inc.) or a-b-Actin (A5441,
Sigma-Aldrich, St. Louis, MO) were used to detect the
corresponding proteins. Additionally, the molecular
weights of TRBP and Beta-actin are very close. Thus in
order to avoid stripping the membrane between each
probing, the secondary antibodies—anti-mouse-800nm
(610-132-121, Rockland, Gilbertsville, PA) or anti-
rabbit-680nm (A21109, Molecular Probes/Invitrogen)—
were detected at two different wavelengths on an
Odyssey Infrared imaging system (LI-COR biosciences,
NE). Scanned results in green, red or yellow were
visualized as black and white. The reproducibility of the
immunodepletions was veriﬁed four times.
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For incubations with radio-labeled siRNAs, single-
stranded siRNAs were 50-end labeled with T4 polynucleo-
tide kinase (New England Biolabs) and g-
32P-ATP (MP
Biochemicals) for 1 h and puriﬁed with a G25 column (GE
Healthcare). For siRNA duplexes, independently radio-
labeled sense and antisense strands were mixed and
annealed at 95 C in a heat block for 2min and allowed
to cool slowly at room temperature by removing the heat
block from the heat source until they reached ambient
temperature. SiRNA duplexes that were radiolabeled
after annealing yielded identical results. Unlabeled
EGFPS1-A, –B, hnRNPH-1 and -3 siRNA duplexes
were used as cold competitors. For siRNAs with only
one 50-end-labeled strand, the sense or antisense strand
was annealed with the unlabeled complementary strand
to generate S*/AS or S/AS* EGFPS1A or unlabeled
sense and antisense strands were annealed and used as a
cold competitor. Of total protein in buffer D, 15.0mg were
incubated with 1nM (4 10
4 c.p.m.) of labeled siRNA
duplexes for 30min at room temperature. In competition
assays, cold siRNA competitors of concentrations at 2, 5,
10, 25, 50 or 100nM were incubated in addition to 1nM
of labeled EGFPS1A siRNA duplex. The samples were
mixed with 4X native gel loading dye and resolved in a
4.5% non-denaturing polyacrylamide gel (29:1)
(20 30cm glass plates, 1.5mm spacers) with 1X TBE
for 3.0 h at 200V and 4 C. The gel was dried at 80 C
for 1 h for autoradiography. Quantiﬁcations of the
RNA–protein complexes were performed with densito-
metric scanning of the gel (Typhoon scanner). The
percent complex binding was calculated as percent
bound [bound/ free+bound) 100] of siRNAs relative to
input siRNA incubated without the cell extract.
Percentage bound of the HEK293 WCE sample was set
to 100%, and relative intensities of complexes formed in
immunodepleted cell extracts were calculated accordingly.
For the gel supershift assays, HEK293 cell extract
(15.0mg of total protein) was incubated with 1mgo f
antibody speciﬁc for Dicer (ab14601), Ago1 (07-599,
Upstate, Lake Placid, NY), Ago2 (07-590, Upstate) or
1ml TRBP antibody Ab672 (51) for 15min prior to the
incubation with siRNA duplexes. The samples were
resolved in a composite polyacrylamide (3%)–agarose
(0.5%) gel and run for 7 h at 100V at 4 C. The gel was
ﬁxed with a 10% Acetic Acid: 10% methanol mix for
20min and dried at 80 C for 1 h for autoradiography.
The antibodies used in the supershifts were also used in
western blot analyses (49) to detect the proteins in the cell
extract. The assays described above were repeated
multiple times and representative gel ﬁgures are shown
in this study.
RT-qPCR
Twenty-four hours after the second round of transfection
with 20-nM siRNA-targeting Dicer, Ago2 or TRBP, and
200-pM siEGFPS1A variants, RNA was extracted with
RNA STAT60 (TEL-TEST), treated with Turbo
DNA-Free Kit (Ambion, Austin, Texas) and reverse-
transcribed into complementary DNA (cDNA) using
random hexamer primers and Maloney Murine
Leukemia Virus (MMLV) reverse transcriptase
(Invitrogen, Carlsbad, California). One RNA sample of
each preparation was processed without MMLV RT as
a negative control in subsequent real time PCR reactions.
Quantitative analysis of Dicer, Ago2 and TRBP expres-
sions was performed by real time PCR SYBR Green I (Bio
Rad) analysis (C1000 Thermal Cycler, Bio Rad, Hercules,
California). Dicer, Ago2 and TRBP expression was
detected using 50ng of cDNA, ampliﬁed with correspond-
ing primer sets Dicer-A (50-CATGGATAGTGGGATGT
CAC-30), Dicer-B (50-CTACTTCCACAGTGACTC
TG-30); Ago2-A (50-CGCGTCCGAAGGCTGCTC
TA-30), Ago2-B (50-TGGCTGTGCCTTGTAAAACGC
T-30) and 50TRBP (50-GGGCTGCCTAGTATAGAG
C-30), 30TRBP-2 (50-GACCCGGAAGGTGAAATT
AG-30). GAPDH expression was detected as internal
control using 50ng of cDNA, with primers GAPDH-A
(50-CGCTCTCTGCTCCTCCTGTT-30) and GAPDH-B
(50-CCATGGTGTCTGAGCGATGT-30). PCR condi-
tions are as follows: (i) Dicer, Ago2 and GAPDH PCR:
95 C for 5min, followed by 40 cycles of 95 C for 30 s,
60 C for 30 s and 72 C for 1min, and (ii) for TRBP and
GAPDH: 95 C for 5min, followed by 40 cycles of 95 C
for 1min, 60 C for 1min and 72 C for 1min.
RESULTS
Differential whole-cell-extract complex formation and
target knockdown correlate with siRNA end structure
To test the structural requirements for binding of siRNAs
to components of whole cell extracts and target
knockdown, various 30-end modiﬁed versions of a single
EGFP-targeting siRNA (EGFPS1) were incubated in
whole-cell extracts for evaluation of complex formation
and in cell culture for target down-regulation assays.
The sequence of the antisense (guide) strand of the
EGFPS1A variants was kept constant and only the
sense strand was varied to create the differing types of
overhangs (Figure 1a). The results of the binding assays
revealed that differences in complex formation are sensi-
tive to the 30-end structure. When the siRNA duplexes in
Figure 1a were incubated with a HEK293 whole-cell
extract, the strongest binding was observed with the 2-nt
30 overhang (EGFPS1A or 19+2 in Figure 1a and b) and
was reduced with subsequent alterations in the siRNA end
structure. Binding reached <40% with the 21+0 (blunt
30-end) siRNA and complex formation and was further
reduced with 50 overhangs (20-1 or 19-2 in Figure 1a
and b), indicating that the complex is formed preferen-
tially with siRNAs via the 30 overhangs, consistent with
binding being initiated with siRNA 30 overhang-PAZ
domain interactions.
To determine whether the 30-end modiﬁcations
introduced in the EGFPS1A variants affect RNAi
efﬁcacy, the above siRNA variants were tested in the
Dual Luciferase reporter assays (Figure 1c). Silencing ef-
ﬁciency for many siRNAs is known to be concentration
dependent. Since a high concentration of a given siRNA
in an experimental setting could result in masking the
Nucleic Acids Research,2011, Vol.39, No. 4 1513effects of various structural features, we chose to use con-
centrations of 20 and 200 pM, or a concentration at the
EGFPS1A IC50 value (Figure 3) versus one 10-fold above
this. The variant siRNAs were co-transfected with the
psiEGFPS1-S reporter plasmid in HEK293 cells and the
effects on Renilla luciferase activity were monitored. The
19+2 siRNA was most potent, consistent with it being the
best binder in the extracts. The other siRNAs followed in
graded fashion with the +1, blunt,  1 and  2 siRNAs
being progressively worse in target knockdown. These
Figure 1. The effect of 30 overhang on complex formation and RISC function. (a and b) Four variants of EGFPS1A siRNA differing in the number
of nucleotides at 30-end (a) were evaluated for complex formation competence (b)+2,+1,+0,   1,  2 indicate numbers of nucleotides at the 30-end
as overhangs [19+2, 20+1, 21+0 (blunt ends), 20 – 1 (with 1-nt 50 overhangs) and 19 – 2 (with 2-nt 50 overhangs)]. The bottom strands are the
antisense sequences and the upper strands the sense sequences. Without HEK293 whole-cell extract, 19+2 was included as a negative control. The
band shifts were quantiﬁed by densitometric scanning of the gel (Typhoon scanner) and percent bound siRNAs were calculated by [bound/
(free+bound) 100] of siRNAs relative to input siRNA without cell-extract incubation. The assays were conducted multiple times with similar
results, and a representative gel is shown here. (c) Dual Luciferase assays. To determine the efﬁciency of the 30-end modiﬁed siRNAs in intracellular
target knockdown efﬁciency, silencing by the antisense strand of the end modiﬁed EGFPS1A siRNA duplexes was assayed in HEK293 cells by
co-transfecting the psi-EGFP-S1 sense reporter and 20- or 200-pM siRNAs. Target-speciﬁc Renilla luciferase expression was normalized to the
control Fireﬂy luciferase expression for all replicates (determined from multiple co-transfections).
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in the cell extracts.
We next tested the speciﬁcity of complex formation with
single- or double-stranded siRNAs to determine if the
high-molecular weight complex observed is an RNA
duplex speciﬁc (Figure 2). When either the EGFPS1A
labeled sense (S*) or antisense (AS*) strands were tested
individually in the binding assays, no binding to the
high-molecular weight complex was observed (Figure 2)
whereas a faster migrating complex was observed with
both of the single-strand RNAs. We further tested the
duplex requirement of the complex using EGFPS1A con-
taining either one (S*/AS or S/AS*) or both (S*/AS*)
50-radiolabeled strands. Both S*/AS and S/AS* were
incorporated into the complex, and cold EGFPS1A (S/
AS) efﬁciently competed with the S*/AS* siRNA–
protein complex, conﬁrming that the complex in this
study is duplex speciﬁc (Figure 2a). These observations
demonstrate that the complex formation in this study is
preferentially with the duplex form of siRNAs. Our ob-
servations are also consistent with reported observations
that the human RLC forms exclusively with the duplex
form of siRNAs (27–29).
To test the complex formation with several different
canonical siRNAs harboring 19-base duplexes and 2-nt
overhangs, we created a set of ten siRNAs targeting
EGFP (EGFPS1-A–J, Figure 3a) in which each sequence
is shifted by 1nt towards the 50-end of the target RNA.
Several, but not all of the siRNAs incorporated published
siRNA features that contribute to the overall efﬁciency of
RNAi (such as an A at position 3 or 19 and 30–50%
overall GC content in the passenger strand)
(37,39,52–54). Duplex end free energies—from 2 to 5bp
on both the 50- and 30-ends—of the siRNAs were also
calculated and are listed in Table 1, panel a. When the
10
32P-labeled anti-EGFP siRNA duplexes were incubated
in HEK293 cell extracts and subjected to EMSA analyses,
the duplexes formed complexes that migrated similarly.
However, while the majority of siRNAs formed strong
complexes, EGFPS1B, I and J formed weak complexes
(Figure 3b). We next examined the relative levels of
siRNA-directed mRNA knockdown using Dual
Luciferase assays. IC50 values for both sense (S) and anti-
sense (AS) targets of the siRNAs were determined using
dose-dependent target knockdown measurements
(Figure 3c and Supplementary Figure S1). When the
EGFPS1 siRNAs were co-transfected with Renilla
luciferase target reporter plasmids—psiEGFPS1-S or
psiEGFPS1-AS (40)—into HEK293 cells, differential
knockdown efﬁciencies of the siRNAs were observed
(Figure 3c). The general trend observed was that the
siRNAs with the stronger complex formation percentages
(Figure 3b) had better overall combined IC50 values
(Figure 3c). In contrast, the three siRNAs with the
poorest complex formation percentages (EFGPS1B, I
and J, Figure 4b) had high-combined IC50 values
(Figure 3c), and in the case of S1J there was no
measureable target knockdown for the psi-EGFPS1-AS
target (Figure 3c).
As representatives of good and poor binders in the
HEK293 cell extract assay, EGFPS1A and B were subse-
quently incubated with HCT116 cell extracts. Consistent
with the observation from the HEK293 cell extract,
EGFPS1A and B formed strong and weak complexes, re-
spectively, in the HCT116 cell extract (data not shown),
validating that the siRNA-binding differentials are not
extract dependent.
To further explore the relationship between complex
formation in the whole-cell extracts and RNAi efﬁcacy,
we created an additional set of siRNAs targeting a
human gene encoding the heterogeneous nuclear
ribonucleoprotein (hnRNP) H and tested these for
Figure 2. Duplex speciﬁcity of siRNAs for complex formation.
(A) Duplex requirement for complex formation. Sense (S*) or antisense
(AS*) strand of EGFPS1A siRNA was incubated separately in the cell
extract, and their gel shift patterns were compared with the intact
EGFPS1A duplex. The duplex speciﬁcity of the complex was further
tested with EGFPS1 A siRNA containing either one (S*/AS or S/AS*)
or both (S*/AS*) 50-labeled strands (lanes 3–6). Cold S/AS was added
as a competitor (lane 4). Both S*/AS and S/AS* EGFPS1A were
incorporated into the complex (arrow).
Nucleic Acids Research,2011, Vol.39, No. 4 1515complex formation in HCT116 whole cell extracts (Figure
4). Seven 21-nt-long siRNAs (hnRNP H1–7) were
designed with their sequences shifted 1nt toward the
30-end of the target RNA hnRNP H (Figure 5a) (40)
and these were evaluated in the extracts by EMSA. As
with the ﬁrst set of siRNAs, duplex end-free energies—
from 2 to 5bp on both the 50- and 30-ends—of the
siRNAs were also calculated and are listed in Table 1,
panel b. When the seven
32P-labeled anti-hnRNPH
siRNA duplexes were incubated in HCT116 cell extracts
and subjected to EMSA analyses, the duplexes formed
complexes that migrated similarly (Figure 4b). However,
among the seven anti-hnRNP H siRNAs, which were
shifted by a single base from each other, we observed a
range of binding efﬁciencies: hnRNP H1, H2, H4 and H7
were effectively incorporated into the complex, whereas
Figure 3. Ribonucleoprotein complex formation and EGFPS1 siRNA silencing. (a) A set of 10 anti-EGFP siRNAs-targeting EGFP Site I (40).
Upper strand is sense; bottom strand is antisense. (b) Gel-shift assays. Anti-EGFPS1-A to -J siRNAs were incubated with HEK293 cell extract and
resolved in a 4.5% non-denaturing gel. The band shifts were quantiﬁed as described in Figure 1. The assays were conducted multiple times with
similar results, and a representative gel is shown here. (c) Determination of EGFPS1 siRNA IC50 values. HEK293 cells were co-transfected with
either psiEGFPS1-Sense or -Antisense reporter plasmid and an siRNA ranging from 0.2 pM to 1.5nM in serial dilutions (a minimal of 10 points
measurements). Cell lysates collected 24-h post-transfection was subjected to the Dual-Luciferase Reporter Assay System (Promega) (dose-dependent
target knockdown measurement curves are shown in Supplementary Figure S1). The n.a. indicates knockdown data were not obtainable for the
passenger strand of S1J.
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4b).
To determine the target knockdown efﬁcacies of the
siRNAs in intact cells the relative levels of target inhib-
ition in HCT116 cells was evaluated using Dual Luciferase
assays. The reporter system contained an hnRNPH PCR
fragment in either a sense (psi-H1-S) or antisense
(psi-H1-AS) orientation in the 30-UTR of a Renilla
luciferase reporter gene (40). The individual siRNAs
were co-transfected with the sense or antisense oriented
target plasmids and IC50 values were determined for
both siRNA strands (Figure 4c and Supplementary
Figure S2). The three siRNAs that showed poor
complex formation (H3, H5 and H6) had one or both
strands with high-IC50 values, whereas those that had
stronger complex interactions (H1, H2, H4 and H7) had
overall lower combined S/AS IC50 values (Figure 4c).
The differential strength of complex formation between
EGFPS1A versus EGFPS1B and hnRNPH1 versus
hnRNPH3 were examined in greater detail using cold
siRNAs as competitors for complex formation
(Figure 5). Using EGFPS1A as a radio-labeled ligand,
unlabeled EGFPS1A, EGFPS1B, hnRNPH1 or
hnRNPH3 at 1:2 to 1:100 molar excess were incubated
in the HEK293 cell extracts. When hnRNPH1 (IC50S and
AS=9.03 and 5.04 pM, Figure 4c) was incubated with
EGFPS1A (IC50S and AS=18.5 and 17.6 pM, Figure 3c),
it competed effectively throughout the range of concentra-
tions tested, while EGFPS1B (IC50S and AS=50.4 and 80.4
pM, Figure 3c) was a weak competitor. HnRNPH3 (IC50S/
AS=29.7 and 7.66 pM, Figure 4c) was moderately com-
petitive with EGFPS1A for complex formation. These
results demonstrate that siRNAs with good potency in
cells are good competitors for complex formation in cell
extracts, and vice versa, implicating selective siRNA
incorporation takes place in the RISC-loading complex
(RLC) as well as in RISC itself.
Examination of the roles Dicer, TRBP and Ago2 in
complex formation
The results described above were carried out using either
the HEK293 or HCT116 cell lines. In order to further
explore the complex composition, we carried out addition-
al biochemical experiments in the HEK293 cell extracts.
The human RLC consists of Ago2, Dicer and TRBP
(26–29). To determine whether any of these components
are involved in the siRNA-complex binding observed in
this study, we carried out antibody-mediated super-shift
assays with HEK293 cell extracts using antibodies against
Dicer, TRBP, Ago2 (and Ago1) to monitor complex for-
mation with the EGFPS1A and hnRNPH1 siRNAs
(Figure 6). Addition of the anti-Dicer antibody resulted
in a strong super-shift of the complex whereas the
anti-TRBP antibody yielded a weak but reproducible
supershift. These results indicate that the complex
observed in Figures 1–3 contain at least Dicer and
TRBP, consistent with the previous observation by
Pellino et al. (55). Although no supershifts were
observed with the anti-Ago2 or anti-Ago1 antibodies,
these antibodies did recognize the cognate proteins in
the HEK293 whole cell extract (Figure 6).
To further analyze the complex components, Dicer,
TRBP, Dicer/TRBP, Ago2 or Ago2/TRBP, immuno-
depletions were carried out and subsequently used in
EMSAs (Figure 7). The efﬁciencies of the
immunodepletions were also evaluated by western-blot
analyses (Figure 7). HEK293 cell extracts immuno-
depleted of Dicer and/or TRBP (Id Dicer, Id TRBP, Id
Dicer/TRBP), and Ago2 and TRBP (Id Ago2/TRBP)
resulted in a loss of siRNA binding to the major
Table 1. Duplex end-free energy calculations (kJ/mol)
siRNA 50-duplex end 30-duplex end Sum of duplex ends
2bp 3bp 4bp 5bp 2bp 3bp 4bp 5bp 2bp 3bp 4bp 5bp
Panel a
S1A  1.8  5.1  8.4  10.5  2.1  5.5  7.6  9.7  3.9  10.6  16  20.2
S1B  4.6  6.8  10.1  13.4  5.6  7.7  9.8   12.2  10.2  14.5  19.9  25.6
S1C  2.9  5.3  7.5  10.8  2.5  4.6  7  8.1  5.4  9.9  14.5  18.9
S1D  2.5  4.6  7  9.2  2.8  5.2  6.3  8.4  5.3  9.8  13.3  17.6
S1E  4.6  6.7  8.8  11.2  3.6  4.7  6.8  9.2  8.2  11.4  15.6  20.4
S1F  1.7  5.1  7.2  9.3  0.7  2.8  5.2  6.1  2.4  7.9  12.4  15.4
S1G  1.6  3.7  7.1  9.2  2.2  4.6  5.5  7.7  3.8  8.3  12.6  16.9
S1H  2.5  3.4  5.5  8.9  4.6  5.5  7.7  9.8  7.1  8.9  13.2  18.7
S1I  4.2  6.3  7.2  9.3  0.5  2.7  4.8  5.7  4.7  9  12  15
S1J  5.5  8.9  11  11.9  1.8  3.9  4.8  7.2  7.3  12.8  15.8  19.1
Panel b
H-1  0.5  2.7  4.8  5.7  2.7  4.8  5.9  8.3  3.2  7.5  10.7  14
H-2  1.8  3.9  4.8  6.9  1.7  4.1  6.2  7.3  3.5  8  11  14.2
H-3  2.7  3.6  5.7  8.1  2.7  3.6  6  8.1  5.4  7.2  11.7  16.2
H-4  1.7  3.8  6.2  7.1  1.8  3.9  4.8  7.2  3.5  7.7  11  14.3
H-5  2.4  4.8  5.7  6.8  4.6  6.8  8.9  9.8  7  11.6  14.6  16.6
H-6  4.6  5.5  6.6  9  2.4  4.8  7  9.1  7  10.3  13.6  18.1
H-7  0.5  1.6  4  6.1  1.7  3.8  6.2  8.4  2.2  5.4  10.2  14.5
Boxes in gray represent thermodynamically more stable ends and numbers in bold face represent the most stable free-energy values among the
siRNAs tested in each group.
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cell extract (Id Ago2, Figure 7), suggesting poor recogni-
tion of Ago2 by this antibody, perhaps due to interactions
of Ago2 with other proteins in the extracts. Nevertheless,
residual levels of Ago2 in Id Dicer, Id TRBP and Id Dicer/
TRBP cell extracts had no effect on complex formation,
consistent with the previous report that Ago2 does not
associate with siRNA duplexes by itself (27). It is of
interest to note that the combined use of anti-Ago2 and
TRBP antibodies resulted in depletion of Ago2 in addition
to Dicer and TRBP and this also abolished complex for-
mation. This result is most likely a consequence of tight
interactions among TRBP, Dicer and Ago2 (27). Most
importantly we observed loss of siRNA gel shifts when
the cell extracts were immunodepleted of Dicer, or the
Dicer/TRBP heterodimer (Figure 7, lanes 4–6 and 8 in
the left panel, and lanes 3–5 and 7 in the right panel). In
total, these observations support Dicer as the
siRNA-binding factor in the cell extracts.
To further explore the role of Dicer in the complex for-
mation we replenished the Dicer immunodepleted extracts
using puriﬁed recombinant Dicer and/or TRBP and tested
for EGFPS1A complex formation (Figure 8). While
rTRBP alone had no effect on complex restoration in
both Id Dicer (lane 5) or Id TRBP cell extracts (lane
13), addition of rDicer or rDicer in combination with
rTRBP (lanes 6, 7, 12 and 14) resulted in restoration of
the siRNA/complex formation (Figures 8a–c).
Figure 4. Ribonucleoprotein complex formation and hnRNPH siRNA silencing. (a) A set of seven hnRNPH siRNAs targeting the hnRNP H site I
(40). Upper strand is sense, lower strand is antisense. (b) Gel-shift assays. Anti-hnRNPH siRNAs were incubated with (+) or without ( ) HCT116
cell extract and resolved in a 4.5% non-denaturing gel. The band shifts were quantiﬁed as described in Figure 1. The percent bound of each siRNA is
shown under the corresponding gel lane. The assays were conducted multiple times with similar results, and a representative gel is shown here.
(c) Determination of hnRNPH1 siRNA IC50 values. HCT116 cells were co-transfected with either psi-H1-Sense or -Antisense reporter plasmid and
an siRNA ranging from 0.2 pM to 1.5nM in serial dilutions (a minimal of 10 points measurements). Cell lysates collected 24-h post-transfection was
subjected to the Dual-Luciferase Reporter Assay System (Promega) (Dose dependent target knockdown measurement curves are shown in
Supplementary Figure S2).
Figure 5. Competition assays. The speciﬁcity and requirement for
siRNA duplexes for complex formation were examined using competi-
tion assays. Duplex requirements for complex formation were tested
with radio-labeled EGFPS1A siRNA mixed with 2-, 5-, 10-, 25-, 50-
or 100-fold molar excess of cold EGFPS1A, -B, hnRNPH1 or H3.
Quantiﬁcations of the RNA–protein complexes were performed using
densitometric scanning of the gel (Typhoon scanner).
1518 Nucleic Acids Research, 2011,Vol.39, No. 4Given the differential complex formation of several of
the siRNAs described above, we next asked if Dicer alone
can discriminate binding of a strong versus weak complex
forming siRNA. To do this rDicer was incubated with
either the EGFPS1-A or -B siRNA duplexes. As we
observed in the high-molecular weight complex formation,
rDicer alone showed differential binding afﬁnities between
these two siRNAs, forming a much stronger interaction
with the EGFPS1A than with the EGFPS1B duplex
(Supplementary Figure S3). Although rDicer aggregated
and was poorly resolved in the composite gel, the differ-
ential binding was reproducible.
To dissect the relative roles of Dicer, Ago2 and TRBP
in selective incorporation of siRNAs in vivo, we used
RNAi to knockdown each of these proteins and assayed
for EGFPS1A-mediated target knockdown using the
panel of EGFPS1A siRNAs that differ in their 30-end
structures (depicted and tested in Figure 1). If Dicer
binding initially determines the 30-end structure and
guide strand selection, the differential efﬁciencies of the
EGFPS1A variants should be absent in Dicer knockdown
cells. Of course knockdown of Ago2 would also reduce
RNAi overall since it is required for the RNAi effector
step of cleaving the target transcripts. We compared the
knockdowns of EGFP via the EGFPS1A panel in
HEK293 in cells pre-treated with siRNAs targeting
Dicer, Ago2 or TRBP (Figure 9). Consistent with a key
role for Dicer in siRNA selection, the previously observed
differences in knockdown efﬁciencies of the EGFPS1A
variants were substantially reduced in cells pre-treated
with the anti-Dicer siRNA. In these cells, we determined
that levels of Dicer and Ago2 expression were repressed
 85% and 65%, respectively (Supplementary Figure S4).
Although TRBP mRNA levels were reduced by  60%,
the effects of this reduction on the differential knockdown
efﬁciencies by the EGFPS1A panel were minimal, which is
Figure 7. Analysis of RISC components required in high-molecular-complex formation. Gel-shift assays. EGFPS1A duplex was incubated with
HEK293 cell extracts immunodepleted of Dicer (Id Dicer), TRBP (Id TRBP), Dicer and TRBP (Id Dicer/TRBP), Ago2 (Id Ago2) or Ago2 and
TRBP (Id Ago2/TRBP). Evaluation of immunodepletion of RISC proteins with western blot analyses was shown on the right. Of Id cell extracts,
150mg were loaded on a 8% SDS–PAGE gel. Pre-immune serum was used as an immunodepletion control.
Figure 6. Analysis of proteins comprising the complex. Super
shift assays. a-Dicer, a-TRBP, a-Ago2 or a-Ago1 antibodies were
added to the HEK293 cell extract and incubated for 15min prior to
addition of either EGFPS1A or hnRNPH1 siRNA. Western analyses
of proteins detected with the antibodies were also shown on the right.
Of total protein, 50mg for detection of Dicer and Ago1 or 150mg for
Ago2, TRBP and b-actin was loaded on 8% SDS–PAGE gels.
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further validate these results, we also tested the effect of
Dicer knockdown on siRNA-triggered gene silencing by
comparing knockdown efﬁciencies of hnRNPH5 and H6
in siDicer-treated HEK293 cells (Supplementary Figure
S5). When the siRNAs were co-transfected with the
psi-H1-S or psi-H1-AS reporter plasmid at 200 pM, asym-
metric knockdowns of the sense or antisense targets by the
siRNA duplexes were observed; however knockdown
efﬁciencies of hnRNPH5 and H6 siRNAs were substan-
tially reduced in siDicer treated cells (Supplementary
Figure S5). Our observations indicate that the overall
efﬁcacies of the siRNAs were diminished in the Dicer
knockdown cells, consistent with previous observations
(27,56), which is most likely a consequence of disruption
of the RLC.
To discriminate the selective binding aspect of Dicer
from direct incorporation of the siRNAs into Ago2, we
modiﬁed EGFPS1A to generate an asymmetric 27/
25-nt-long Dicer substrate form (DsiRNA)—a blunt end
with two deoxyribonucleotide bases at the 30-end of the
passenger strand—forcing the duplex to be bound and
undergo Dicer cleavage activity. EGFPS1B was also
modiﬁed to a DsiRNA form for direct comparison, and
the IC50 values were determined for both DsiRNAs
(Figure 10a and b). For both EGFPS1A and B
DsiRNAs, the strand harboring the 2-nt 30 overhang
was predominantly selected as the guide strand (IC50,
Dsi-S1A-AS=31.9 pM, IC50, Dsi-S1A-Sense=101 pM; IC50,
Dsi-S1B-AS=27.5 pM, IC50, Dsi-S1B-Sense=433 pM), con-
sistent with previous observations (40). In contrast, the
dominant selection of the antisense strand (relative to
the sense EGFP target) was absent or less pronounced
with the use of 19+2 siRNAs. Both the dsiRNAs and
siRNAs form dicer-dependent complexes in whole-cell
extracts (57) (Supplementary Figure S6). These results
support a model in which the orientation of Dicer
binding to its substrates sets the preference for which
strand will be chosen to act as the guide strand. Taken
together, our observations suggest that the initial Dicer–
DsiRNA interaction is an important determinant for es-
tablishing siRNA-strand selection in RISC and ultimately
Figure 8. Analysis of siRNA–RISC complex formation. (a) Reconstitution of the siRNA complex with recombinant proteins. Id Dicer (left) or Id
TRBP (right) cell extracts were mixed with 2mg of recombinant Dicer, 80ng of recombinant TRBP or both proteins to rescue complex formation.
(b and c) Percent-bound-reconstituted siRNA complexes were calculated relative to the HEK293 WCE which was set as 100%.
1520 Nucleic Acids Research, 2011,Vol.39, No. 4the potency of the siRNAs. The Dicer substrates force
Dicer to enter the RNA via its PAZ domain and the
2-base 30 overhang of the Dicer substrate whereas 19+2
siRNAs allow Dicer to bind from either end using the
2-base 30 overhang for PAZ domain interactions.
DISCUSSION
We have used siRNA binding to a high-molecular-weight
complex in whole-cell extracts to better understand what
cellular factors are involved in the initial binding and dis-
criminatory selection of highly functional versus poorly
functional siRNAs. In particular, we have been interested
in what happens to siRNAs following transfection into
cultured cells. We ﬁnd that the extent of siRNA complex
formation reﬂects siRNA-directed overall target
knockdown efﬁciency in cultured cells. Using antibodies
to core RNAi proteins to determine the key proteins of
the complex, we ﬁnd that it minimally consists of
Dicer/TRBP, presumably as the pre-RLC. Our observa-
tions suggest that human RISC silencing efﬁciency with
exogenously supplied siRNAs reﬂects the extent of
siRNA-pre-RLC formation.
Previously, mammalian Dicer was shown to be dispens-
able for RISC assembly and siRNA-mediated cleavage of
target RNA transcripts (41–43). In contrast, the absence
of a functional mouse Dicer resulted in a lack of
shRNA-mediated RNAi (43), showing that Dicer-
cleavage activity was necessary to generate the siRNAs
from this precursor. The lack of a Dicer requirement
for pre-formed siRNA function led to the conclusion
that only Ago2 was required for siRNA selection.
Conversely, two groups demonstrated that the absence
of Dicer abolished gene silencing effects (27,56). Our
results suggest that when present, Dicer itself binds
siRNAs that mimic the products of Dicer cleavage
(19bp + 2-nt 30 overhangs) and Dicer can serve as a
‘gate-keeper’ discriminating between potent and
non-potent siRNAs by selective binding of the siRNAs
in the pre-RLC.
Schwarz et al. reported that 2–4bp on both ends of a
siRNA are important for their relative loading efﬁciency
into RISC in Drosophila (35). Our calculated duplex
end free energies for siRNAs used in this study
(Table 1) are consistent with these observations.
Moreover, we observed that in general, siRNAs with
thermodynamically unstable base pairs at both ends ef-
fectively form high-molecular-weight complexes in cell
extracts and have better overall silencing efﬁciencies.
These observations suggest that the thermodynamic
properties of 2–4bp on both ends of effective siRNAs
are used as functional determinants by the pre-RLC
and determine overall silencing efﬁciency in humans as
well.
It is widely known that siRNAs targeting the same
region of a target mRNA can have a wide range of
Figure 9. The effect of 30 overhang on RISC function in Dicer kd, Ago2 kd and TRBP kd cells. Efﬁciencies of target downregulation by four
variants of EGFPS1A siRNA (Figure 1) were evaluated using Dual Luciferase assays with siDicer, siAgo2 or siTRBP treated HEK293 cells. To
determine effects of Dicer, Ago2 or TRBP knockdowns on the silencing activity of the siEGFPS1A variants described in Figure 1, HEK293 cells
were treated with 40nM siDicer, siAgo2 or siTRBP for 2 days prior to the co-transfection. For the second round of transfection, Dicer kd, Ago2 kd
or TRBP kd cells were transfected with the psi-EGFP-S1 sense reporter and 200pM siEGFPS1A variants. Target-speciﬁc Renilla luciferase expres-
sion was normalized to the control Fireﬂy luciferase expression for all replicates (determined from four co-transfections).
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features such as an A at position 3 or 19 and 30–50%
overall GC content in the passenger strand (37,39,52–54)
are widely used to predict potent siRNAs in addition to
thermodynamic end properties. However, the importance
of the AU base pair at these positions remained elusive.
Using two sets of siRNAs targeting EGFP site I and
hnRNP H site I (40), we observed that siRNAs containing
an A:U base pair at positions 1 and/or 19 result in more
effective binding to the high-molecular-weight complex
than those with C:G pairs at these positions. This
ﬁnding is consistent with the previous report of Katoh
and Suzuki (58) which suggested that an AU base pair
at these positions makes the siRNA a good substrate for
the pre-RLC interaction and selection as an effective
siRNA for target downregulation.
The manipulations of the 2-nt 30 overhangs, which
resulted in reductions in target downregulation
(Figure 1) verify that the presence of a 1- or 2-nt 30
overhang is required not only for efﬁcient binding to the
high-molecular-weight complex, but is also required
for efﬁcient target downregulation. Previously, Pellino
et al. (55) reported that the complex observed with
HEK293 cell extracts contained Dicer. Our siRNA gel
shift and binding assays along with the immunodepletion
assays in HCT116 and HEK293 cell extracts demonstrate
that Dicer is required for siRNA binding in these extracts,
a result which is consistent with reports that the initial
siRNA–Dicer interaction is via the 2-nt 30 overhang
(59,60).
The marked differences in Dicer/TRBP binding to
siRNAs and the correlations with efﬁcacy of target
Figure 10. Comparative analyses of guide strand selection for 21-mer and 25/27-mer Dicer substrate siRNAs. Target knockdowns for sense and
antisense strands of siRNA EGFPS1A (a) and EGFPS1B (b) in 21-mer and Dicer substrate formats were carried out using co-transfections of the
siRNAs with either the psi-EGFP-S sense reporter (red) or psi-EGFP-AS antisense reporter (black) in HEK293 cells. For both targets the 21-nt
EGFPS1 siRNAs (left) or 25/27 DsiRNAs (right) were tested at various concentrations. Target-speciﬁc Renilla luciferase expression was normalized
to the control Fireﬂy luciferase expression for all replicates (determined from multiple co-transfections). Sequences and IC50 values of each siRNA
are shown. For the Dicer substrate siRNAs, the lower case letters represent deoxyribonucleotide containing bases which block Dicer entry.
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only a single nucleotide in sequence, point to the import-
ance of understanding how siRNAs are selected for entry
into RISC. Understanding the rules for effective siRNA
design is further complicated by the fact that siRNAs
which do not bind to Dicer can also be incorporated
into RISC (41–43). We propose though that when Dicer
is present it will preferentially bind and select siRNAs
harboring structurally favorable features, and this inter-
action leads to the subsequent handoff step to Ago2.
Selective binding of Dicer to siRNAs could potentially
determine the strand to be incorporated as a guide strand.
The binding of the PAZ domain to a Dicer substrate
allows the catalytic domain to interact with the opposite
end of the dsRNA. Studies of the interaction of the human
Dicer catalytic site with the PIWI domain of Ago2 (61)
and the binding of the Archaeoglobus fulgidus PIWI
protein with the 50-end of the guide strand in the crystal
structure (62) suggest the coupling of the initiation and
effector steps of RNAi. The handoff of the guide strand
from Dicer to Ago2 via the Dicer-catalytic domain could
explain not only why Dicer processing of longer precur-
sors often increases the efﬁcacy of processed siRNAs
(40,63), but also why the 50-end of the siRNA within
RISC leads to and determines the stable association of
RISC and the target RNA (64). In this regard, Dicer sub-
strates in the studies of Rose et al. (40) have a blunt end
with two deoxybases at the 30-end of the passenger strand,
which precludes Dicer PAZ domain interactions from that
end of the duplex. The polarity of Dicer entry from the
end harboring the 2-base 30 overhang results in substan-
tially reduced function of the passenger strand relative to
that observed with the corresponding 19+2 siRNA
(Figure 10). Moreover, a single-nucleotide shift in the
siRNA relative to the target site also resulted in a strong
bias in guide strand selection for the dsiRNAs as
demonstrated by EGFPS1A-25/27 (IC50,
Dsi-S1A-Sense=101pM) and EGFPS1B-25/27 DsiRNAs
(IC50, Dsi-S1B-Sese=433pM) (Figure 10). Thus, Dicer
interaction with the 2-nt 30 overhang is an important
step in Dicer binding, and for 19+2 siRNAs Dicer can
bind in two orientations. Nevertheless, the thermodynam-
ic end properties of the siRNAs also inﬂuence Dicer
binding as we have demonstrated.
Recent single-particle EM analyses of the
RLC-containing Dicer/TRBP/Ago2, show that Ago2 is
associated with the C-terminal domain of Dicer, while
TRBP is associated with the N-terminal or helicase
domain of Dicer (65,66). This structural conﬁguration
would facilitate Dicer handoff of the 50-end of the guide
strand to Ago2. Our observations that Dicer binds select-
ively to 2-base 30 overhangs, most likely via the PAZ
domain, would orient the enzyme such that the
C-terminal portion of the enzyme is associated with the
50-end of the guide strand to facilitate handoff of the guide
strand to Ago2. An important observation is that the sta-
bility of Dicer binding to an siRNA is not solely mediated
by the 30 2-base overhang, but obviously involves inter-
actions with the duplex itself. This is made evident by the
fact that many of the siRNAs used in our binding analyses
contain the 2-base overhang but are not bound strongly to
the Dicer-containing complex.
Thus far, the binding efﬁciency of Dicer/TRBP to
pre-miRNAs appears to be maintained regardless of
whether or not the pre-miRNA can be cleaved by Dicer
(67). Our work and that of Pellino et al. (55) demonstrate
that Dicer/TRBP can bind to siRNAs as well. However,
these observations are in contrast to a previous study that
human Dicer is incapable of siRNA binding (68).
One possible explanation for this discrepancy is that the
siRNA used in the previous study may fall into the group
of siRNAs that are weak binders to the pre-RLC—similar
to the poor binding siRNAs tested in our study.
While immunodepletion of Dicer (Id Dicer) left-residual
TRBP, Id of TRBP resulted in nearly complete depletion
of Dicer in the HEK 293 cell extracts, as did co-Id of Dicer/
TRBP. These results indicate that the majority of Dicer is
bound to TRBP and that distinctive roles of Dicer and
TRBP augment each other to function as the pre-RLC.
Id of Ago2/TRBP resulted in immunodepletion of Dicer,
TRBP and Ago2 (Figure 7), suggesting that TRBP func-
tions as a bridge between Dicer and Ago2.
We have demonstrated that for many siRNAs what we
deemed as the passenger strand could be more effective at
target knockdown than the desired antisense guide strand.
Since Dicer/TRBP binding to a siRNA duplex determines
the strand to be selected as the guide strand, off-targeting
will often be a consequence of both strands being
incorporated into RISC. Thus the two strands of a
siRNA can also compete with one another for incorpor-
ation into RISC following Dicer selection, thereby poten-
tially reducing the potencies of both.
In conclusion our results demonstrate that human Dicer
plays an important role in selection of efﬁcacious siRNAs
via direct binding to siRNAs that harbor certain structural
features, which include the 2-nt 30 overhangs and the
thermodynamically unstable base pairing at the ends of
the duplex. These results are similar yet distinct from
Drosophila in which R2D2 and Dcr-2 bind to the thermo-
dynamically stable and unstable ends of siRNA duplexes,
respectively. Our results demonstrate that the human Dicer
enzyme can recognize and selectively bind siRNAs with
thermodynamically favorable termini. Our results demon-
strate that an often overlooked feature of 19+2 siRNAs is
the ability of both strands to be chosen for RISC entry.
This is sometimes observed for miRNAs as well, but often
only one strand serves as the guide. In this regard, Dicer
substrate siRNAs mimic the miRNA pathway, providing
strong polarity for guide strand selection, perhaps a useful
attribute for minimizing off target effects and competition
between the two strands for entry into RISC.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors acknowledge members of the Rossi labora-
tory for helpful discussions and support, especially Lisa
Nucleic Acids Research,2011, Vol.39, No. 4 1523Scherer for the critical reading of this article. They are
grateful for the suggestions of Y. Chen, R.J. Lin,
J Shively and J. Termini.
FUNDING
Norwegian Research Council (a postdoctoral fellowship
to M.A.); Arnold and Mabel Beckman Foundation (to
D.K.); National Institutes of Health (grants AI29329,
AI42552 and HL074704 to J.J.R.). Funding for open
access charges: National Institutes of Health National
Heart Lung and Blood Institute and National Institute
of Allergy and Infectious Diseases.
Conﬂict of interest statement. M.A.B. is employed by IDT
DNA, which manufactures siRNAs and dicer substrate
siRNAs. J.J.R. is chairman of the SAB at Dicerna
Pharmacueticals which uses Dicer substrate siRNAs.
REFERENCES
1. Hammond,S.M., Bernstein,E., Beach,D. and Hannon,G.J. (2000)
An RNA-directed nuclease mediates post-transcriptional gene
silencing in Drosophila cells. Nature, 404, 293–296.
2. Hannon,G.J. (2002) RNA interference. Nature, 418, 244–251.
3. Bernstein,E., Caudy,A.A., Hammond,S.M. and Hannon,G.J.
(2001) Role for a bidentate ribonuclease in the initiation step of
RNA interference. Nature, 409, 363–366.
4. Liu,J., Carmell,M.A., Rivas,F.V., Marsden,C.G., Thomson,J.M.,
Song,J.J., Hammond,S.M., Joshua-Tor,L. and Hannon,G.J. (2004)
Argonaute2 is the catalytic engine of mammalian RNAi. Science,
305, 1437–1441.
5. Meister,G., Landthaler,M., Patkaniowska,A., Dorsett,Y., Teng,G.
and Tuschl,T. (2004) Human Argonaute2 mediates RNA cleavage
targeted by miRNAs and siRNAs. Mol. Cell, 15, 185–197.
6. Rivas,F.V., Tolia,N.H., Song,J.J., Aragon,J.P., Liu,J.,
Hannon,G.J. and Joshua-Tor,L. (2005) Puriﬁed Argonaute2 and
an siRNA form recombinant human RISC. Nat. Struct. Mol.
Biol., 12, 340–349.
7. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K.
and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate
RNA interference in cultured mammalian cells. Nature, 411,
494–498.
8. Elbashir,S.M., Lendeckel,W. and Tuschl,T. (2001) RNA
interference is mediated by 21- and 22-nucleotide RNAs.
Genes Dev., 15, 188–200.
9. Elbashir,S.M., Martinez,J., Patkaniowska,A., Lendeckel,W. and
Tuschl,T. (2001) Functional anatomy of siRNAs for mediating
efﬁcient RNAi in Drosophila melanogaster embryo lysate.
Embo J., 20, 6877–6888.
10. Zamore,P.D., Tuschl,T., Sharp,P.A. and Bartel,D.P. (2000) RNAi:
double-stranded RNA directs the ATP-dependent cleavage of
mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25–33.
11. Bagga,S., Bracht,J., Hunter,S., Massirer,K., Holtz,J., Eachus,R.
and Pasquinelli,A.E. (2005) Regulation by let-7 and lin-4
miRNAs results in target mRNA degradation. Cell, 122, 553–563.
12. Grimson,A., Farh,K.K., Johnston,W.K., Garrett-Engele,P.,
Lim,L.P. and Bartel,D.P. (2007) MicroRNA targeting speciﬁcity
in mammals: determinants beyond seed pairing. Mol. cell, 27,
91–105.
13. Brennecke,J., Stark,A., Russell,R.B. and Cohen,S.M. (2005)
Principles of microRNA-target recognition. PLoS Biol., 3, e85.
14. Lee,R.C., Feinbaum,R.L. and Ambros,V. (1993) The C. elegans
heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell, 75, 843–854.
15. Lewis,B.P., Burge,C.B. and Bartel,D.P. (2005) Conserved seed
pairing, often ﬂanked by adenosines, indicates that thousands of
human genes are microRNA targets. Cell, 120, 15–20.
16. Behm-Ansmant,I., Rehwinkel,J., Doerks,T., Stark,A., Bork,P. and
Izaurralde,E. (2006) mRNA degradation by miRNAs and GW182
requires both CCR4:NOT deadenylase and DCP1:DCP2
decapping complexes. Genes Dev., 20, 1885–1898.
17. Giraldez,A.J., Mishima,Y., Rihel,J., Grocock,R.J., Van
Dongen,S., Inoue,K., Enright,A.J. and Schier,A.F. (2006)
Zebraﬁsh MiR-430 promotes deadenylation and clearance of
maternal mRNAs. Science, 312, 75–79.
18. Wu,L., Fan,J. and Belasco,J.G. (2006) MicroRNAs direct rapid
deadenylation of mRNA. Proc. Natl Acad. Sci. USA, 103,
4034–4039.
19. Liu,Q., Rand,T.A., Kalidas,S., Du,F., Kim,H.E., Smith,D.P. and
Wang,X. (2003) R2D2, a bridge between the initiation and
effector steps of the Drosophila RNAi pathway. Science, 301,
1921–1925.
20. Lee,Y.S., Nakahara,K., Pham,J.W., Kim,K., He,Z.,
Sontheimer,E.J. and Carthew,R.W. (2004) Distinct roles for
Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing
pathways. Cell, 117, 69–81.
21. Forstemann,K., Tomari,Y., Du,T., Vagin,V.V., Denli,A.M.,
Bratu,D.P., Klattenhoff,C., Theurkauf,W.E. and Zamore,P.D.
(2005) Normal microRNA maturation and germ-line stem cell
maintenance requires Loquacious, a double-stranded
RNA-binding domain protein. PLoS Biol., 3, e236.
22. Saito,K., Ishizuka,A., Siomi,H. and Siomi,M.C. (2005) Processing
of pre-microRNAs by the Dicer-1-Loquacious complex in
Drosophila cells. PLoS Biol., 3, e235.
23. Liu,X., Jiang,F., Kalidas,S., Smith,D. and Liu,Q. (2006) Dicer-2
and R2D2 coordinately bind siRNA to promote assembly of the
siRISC complexes. RNA, 12, 1514–1520.
24. Bernstein,E., Kim,S.Y., Carmell,M.A., Murchison,E.P., Alcorn,H.,
Li,M.Z., Mills,A.A., Elledge,S.J., Anderson,K.V. and
Hannon,G.J. (2003) Dicer is essential for mouse development.
Nat. Genet., 35, 215–217.
25. Hutvagner,G., McLachlan,J., Pasquinelli,A.E., Balint,E., Tuschl,T.
and Zamore,P.D. (2001) A cellular function for the
RNA-interference enzyme Dicer in the maturation of the let-7
small temporal RNA. Science, 293, 834–838.
26. MacRae,I.J., Ma,E., Zhou,M., Robinson,C.V. and Doudna,J.A.
(2008) In vitro reconstitution of the human RISC-loading
complex. Proc. Natl Acad. Sci. USA, 105, 512–517.
27. Chendrimada,T.P., Gregory,R.I., Kumaraswamy,E., Norman,J.,
Cooch,N., Nishikura,K. and Shiekhattar,R. (2005) TRBP recruits
the Dicer complex to Ago2 for microRNA processing and gene
silencing. Nature, 436, 740–744.
28. Gregory,R.I., Chendrimada,T.P., Cooch,N. and Shiekhattar,R.
(2005) Human RISC couples microRNA biogenesis and
posttranscriptional gene silencing. Cell, 123, 631–640.
29. Haase,A.D., Jaskiewicz,L., Zhang,H., Laine,S., Sack,R.,
Gatignol,A. and Filipowicz,W. (2005) TRBP, a regulator of
cellular PKR and HIV-1 virus expression, interacts with Dicer
and functions in RNA silencing. EMBO Reports, 6, 961–967.
30. Lee,Y., Hur,I., Park,S.Y., Kim,Y.K., Suh,M.R. and Kim,V.N.
(2006) The role of PACT in the RNA silencing pathway.
EMBO J., 25, 522–532.
31. Meister,G., Landthaler,M., Peters,L., Chen,P.Y., Urlaub,H.,
Luhrmann,R. and Tuschl,T. (2005) Identiﬁcation of novel
argonaute-associated proteins. Curr. Biol., 15, 2149–2155.
32. Chendrimada,T.P., Finn,K.J., Ji,X., Baillat,D., Gregory,R.I.,
Liebhaber,S.A., Pasquinelli,A.E. and Shiekhattar,R. (2007)
MicroRNA silencing through RISC recruitment of eIF6. Nature,
447, 823–828.
33. Robb,G.B. and Rana,T.M. (2007) RNA helicase A interacts with
RISC in human cells and functions in RISC loading. Mol. Cell,
26, 523–537.
34. Khvorova,A., Reynolds,A. and Jayasena,S.D. (2003) Functional
siRNAs and miRNAs exhibit strand bias. Cell, 115, 209–216.
35. Schwarz,D.S., Hutvagner,G., Du,T., Xu,Z., Aronin,N. and
Zamore,P.D. (2003) Asymmetry in the assembly of the RNAi
enzyme complex. Cell, 115, 199–208.
36. Tomari,Y., Matranga,C., Haley,B., Martinez,N. and Zamore,P.D.
(2004) A protein sensor for siRNA asymmetry. Science, 306,
1377–1380.
1524 Nucleic Acids Research, 2011,Vol.39, No. 437. Reynolds,A., Leake,D., Boese,Q., Scaringe,S., Marshall,W.S. and
Khvorova,A. (2004) Rational siRNA design for RNA
interference. Nat. Biotechnol., 22, 326–330.
38. Amarzguioui,M., Holen,T., Babaie,E. and Prydz,H. (2003)
Tolerance for mutations and chemical modiﬁcations in a siRNA.
Nucleic Acids Res., 31, 589–595.
39. Ui-Tei,K., Naito,Y., Takahashi,F., Haraguchi,T., Ohki-
Hamazaki,H., Juni,A., Ueda,R. and Saigo,K. (2004) Guidelines
for the selection of highly effective siRNA sequences for
mammalian and chick RNA interference. Nucleic Acids Res., 32,
936–948.
40. Rose,S.D., Kim,D.H., Amarzguioui,M., Heidel,J.D.,
Collingwood,M.A., Davis,M.E., Rossi,J.J. and Behlke,M.A.
(2005) Functional polarity is introduced by Dicer processing of
short substrate RNAs. Nucleic Acids Res., 33, 4140–4156.
41. Murchison,E.P., Partridge,J.F., Tam,O.H., Chelouﬁ,S. and
Hannon,G.J. (2005) Characterization of Dicer-deﬁcient murine
embryonic stem cells. Proc. Natl Acad. Sci. USA, 102,
12135–12140.
42. Martinez,J., Patkaniowska,A., Urlaub,H., Luhrmann,R. and
Tuschl,T. (2002) Single-stranded antisense siRNAs guide target
RNA cleavage in RNAi. Cell, 110, 563–574.
43. Kanellopoulou,C., Muljo,S.A., Kung,A.L., Ganesan,S.,
Drapkin,R., Jenuwein,T., Livingston,D.M. and Rajewsky,K.
(2005) Dicer-deﬁcient mouse embryonic stem cells are defective
in differentiation and centromeric silencing. Genes Dev., 19,
489–501.
44. Tomari,Y., Du,T. and Zamore,P.D. (2007) Sorting of Drosophila
small silencing RNAs. Cell, 130, 299–308.
45. Birmingham,A., Anderson,E.M., Reynolds,A., Ilsley-Tyree,D.,
Leake,D., Fedorov,Y., Baskerville,S., Maksimova,E.,
Robinson,K., Karpilow,J. et al. (2006) 30 UTR seed matches, but
not overall identity, are associated with RNAi off-targets.
Nat. Methods, 3, 199–204.
46. Fedorov,Y., Anderson,E.M., Birmingham,A., Reynolds,A.,
Karpilow,J., Robinson,K., Leake,D., Marshall,W.S. and
Khvorova,A. (2006) Off-target effects by siRNA can induce toxic
phenotype. RNA (New York, NY), 12, 1188–1196.
47. Lin,X., Ruan,X., Anderson,M.G., McDowell,J.A., Kroeger,P.E.,
Fesik,S.W. and Shen,Y. (2005) siRNA-mediated off-target gene
silencing triggered by a 7nt complementation. Nucleic Acids Res.,
33, 4527–4535.
48. Clark,P.R., Pober,J.S. and Kluger,M.S. (2008) Knockdown of
TNFR1 by the sense strand of an ICAM-1 siRNA: dissection of
an off-target effect. Nucleic Acids Res., 36, 1081–1097.
49. Castanotto,D., Sakurai,K., Lingeman,R., Li,H., Shively,L.,
Aagaard,L., Soifer,H., Gatignol,A., Riggs,A. and Rossi,J.J. (2007)
Combinatorial delivery of small interfering RNAs reduces RNAi
efﬁcacy by selective incorporation into RISC. Nucleic Acids Res.,
35, 5154–5164.
50. Daher,A., Laraki,G., Singh,M., Melendez-Pen ˜ a,C.E.,
Bannwarth,S., Peters,A.H., Meurs,E.F., Braun,R.E., Patel,R.C.
and Gatignol,A. (2009) TRBP control of PACT-induced
phosphorylation of protein kinase R is reversed by stress. Mol.
Cell. Biol., 29, 254–265.
51. Daviet,L., Erard,M., Dorin,D., Duarte,M., Vaquero,C. and
Gatignol,A. (2000) Analysis of a binding difference between the
two dsRNA-binding domains in TRBP reveals the modular
function of a KR-helix motif. Eur. J. Biochem./FEBS, 267,
2419–2431.
52. Amarzguioui,M. and Prydz,H. (2004) An algorithm for selection
of functional siRNA sequences. Biochem. Biophys. Res. Commun.,
316, 1050–1058.
53. Holen,T. (2006) Efﬁcient prediction of siRNAs with siRNArules
1.0: an open-source JAVA approach to siRNA algorithms. RNA,
12, 1620–1625.
54. Saetrom,P. and Snove,O. Jr (2004) A comparison of siRNA
efﬁcacy predictors. Biochem. Biophys. Res. Commun., 321,
247–253.
55. Pellino,J.L., Jaskiewicz,L., Filipowicz,W. and Sontheimer,E.J.
(2005) ATP modulates siRNA interactions with an endogenous
human Dicer complex. RNA, 11, 1719–1724.
56. Doi,N., Zenno,S., Ueda,R., Ohki-Hamazaki,H., Ui-Tei,K. and
Saigo,K. (2003) Short-interfering-RNA-mediated gene silencing in
mammalian cells requires Dicer and eIF2C translation initiation
factors. Curr. Biol., 13, 41–46.
57. Soifer,H.S., Sano,M., Sakurai,K., Chomchan,P., Saetrom,P.,
Sherman,M.A., Collingwood,M.A., Behlke,M.A. and Rossi,J.J.
(2008) A role for the Dicer helicase domain in the processing of
thermodynamically unstable hairpin RNAs. Nucleic Acids Res.,
36, 6511–6522.
58. Katoh,T. and Suzuki,T. (2007) Speciﬁc residues at every third
position of siRNA shape its efﬁcient RNAi activity. Nucleic Acids
Res., 35, e27.
59. Song,J.J., Liu,J., Tolia,N.H., Schneiderman,J., Smith,S.K.,
Martienssen,R.A., Hannon,G.J. and Joshua-Tor,L. (2003) The
crystal structure of the Argonaute2 PAZ domain reveals an RNA
binding motif in RNAi effector complexes. Nat. Struct. Biol., 10,
1026–1032.
60. MacRae,I.J., Zhou,K. and Doudna,J.A. (2007) Structural
determinants of RNA recognition and cleavage by Dicer.
Nat. Struct. Mol. Biol., 14, 934–940.
61. Tahbaz,N., Kolb,F.A., Zhang,H., Jaronczyk,K., Filipowicz,W.
and Hobman,T.C. (2004) Characterization of the interactions
between mammalian PAZ PIWI domain proteins and Dicer.
EMBO Reports, 5, 189–194.
62. Kolb,F.A., Zhang,H., Jaronczyk,K., Tahbaz,N., Hobman,T.C.
and Filipowicz,W. (2005) Human dicer: puriﬁcation, properties,
and interaction with PAZ PIWI domain proteins. Methods
Enzymol., 392, 316–336.
63. Kim,D.H., Behlke,M.A., Rose,S.D., Chang,M.S., Choi,S. and
Rossi,J.J. (2005) Synthetic dsRNA Dicer substrates enhance
RNAi potency and efﬁcacy. Nat. Biotechnol., 23, 222–226.
64. Ameres,S.L., Martinez,J. and Schroeder,R. (2007) Molecular basis
for target RNA recognition and cleavage by human RISC. Cell,
130, 101–112.
65. Lau,P.W., Potter,C.S., Carragher,B. and MacRae,I.J. (2009)
Structure of the human Dicer-TRBP complex by electron
microscopy. Structure, 17, 1326–1332.
66. Wang,H.W., Noland,C., Siridechadilok,B., Taylor,D.W., Ma,E.,
Felderer,K., Doudna,J.A. and Nogales,E. (2009) Structural
insights into RNA processing by the human RISC-loading
complex. Nat. Struct. Mol. Biol., 16, 1148–1153.
67. Kawahara,Y., Zinshteyn,B., Chendrimada,T.P., Shiekhattar,R.
and Nishikura,K. (2007) RNA editing of the microRNA-151
precursor blocks cleavage by the Dicer-TRBP complex.
EMBO Reports, 8, 763–769.
68. Provost,P., Dishart,D., Doucet,J., Frendewey,D., Samuelsson,B.
and Radmark,O. (2002) Ribonuclease activity and RNA binding
of recombinant human Dicer. EMBO J., 21, 5864–5874.
Nucleic Acids Research,2011, Vol.39, No. 4 1525